Science & transparency
What the research says. And what it doesn't.
Read this first
Product-class research. Not Ultra RSF-specific results.
The studies below evaluate acellular placental and amniotic biologics as a broader class. They do not establish the effectiveness or safety of Ultra RSF specifically. Individual results vary.
12 mo
In a double-blinded trial of 81 patients with severe knee arthritis, the amniotic biologic group was still improving at one year after cortisone had faded.
JAAOS GRR 2025 ↗200
Patients in a randomized trial where amniotic allograft outperformed hyaluronic acid and saline on pain and function at 3 and 6 months.
Pharmaceuticals 2022 ↗6.6 → 2.9
Average spine pain on a 10-point scale, held at a mean of 21 months after one placental injection in patients who had failed conventional care.
Front Pain Res 2024 ↗Important context
These trials studied acellular placental and amniotic biologics as a product class, not Ultra RSF specifically. Individual results vary.
How care is given
A licensed physician reviews every case before anything is dispensed or administered. Care is adjunctive to your existing medical care and is not intended to diagnose, treat, cure or prevent any disease.